Legal Representation
Attorney
Lawrence M. Green
USPTO Deadlines
Next Deadline
2132 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251118)
Due Date
November 18, 2031
Grace Period Ends
May 18, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 30, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 30, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 23, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 29, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 23, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 29, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 8, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 7, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 7, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 7, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 28, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 28, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 28, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 5, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 5, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 5, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 26, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 11, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 14, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 14, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 25, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 12, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 10, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 10, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 10, 2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 10, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 22, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, epilepsy, physical injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, infection, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, cerebral venous sinus thrombosis, retinal disease and other disease arising from neuronal damage; and testing, inspection, research or development of pharmaceutical preparations for gene therapy or small molecule treatment
First Use Anywhere:
Mar 31, 2025
First Use in Commerce:
Mar 31, 2025
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ASTROCYTES TO NEURONS"